Hexpharm Jaya Laboratories is primarily engaged in medicines, capsuled or ampuled activity. Its headquarters is located in Dki Jakarta. The company was founded in 1988. Hexpharm Jaya Laboratories was founded by PT Kalbe Farma Tbk, a leading pharmaceutical company in Indonesia. As a subsidiary of Kalbe Farma, Hexpharm Jaya focuses on the production and distribution of generic and branded pharmaceutical products. The company's primary business line is the manufacturing of medicines, with a secondary focus on healthcare solutions and services. Hexpharm Jaya operates several branches across Indonesia, ensuring a strong local presence and accessibility to its products. The company's product portfolio includes a wide range of therapeutic categories, such as cardiovascular, anti-infective, and over-the-counter medications. Some of its well-known product brands include Xepathic, Xepacard, and Xepavit. Globally, Hexpharm Jaya is expanding its footprint by exporting its products to several countries in Southeast Asia and beyond. The company is committed to maintaining high standards of quality and compliance with international regulations, which has enabled it to establish a presence in various export markets. Hexpharm Jaya collaborates with numerous healthcare organizations and participates in joint ventures to enhance its research and development capabilities. The company is a member of several pharmaceutical associations, which helps it stay abreast of industry trends and innovations. With a mission to improve the quality of life through accessible healthcare solutions, Hexpharm Jaya Laboratories aims to be a trusted partner in the pharmaceutical industry, focusing on innovation, quality, and customer satisfaction.
Headquarters
Kota Jakarta Timur Kayu Putih Pulo Gadung Dki Jakarta
East Jakarta; Jakarta;
Postal Code: 13210
Contact Details: Purchase the PT Hexpharm Jaya Laboratories report to view the information.
Website: http://www.hexpharmjaya.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service